Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW 5,040.00
-50.00 (-0.98%)
At close: May 29, 2026
Sinsin Pharmaceutical Market Cap
Sinsin Pharmaceutical has a market cap or net worth of 76.46 billion as of June 1, 2026. Its market cap has decreased by -19.62% in one year.
Market Cap
76.46B
Enterprise Value
112.61B
Revenue
118.65B
Ranking
n/a
PE Ratio
6.85
Stock Price
5,040.00
Market Cap Chart
Since February 28, 2017, Sinsin Pharmaceutical's market cap has decreased from 121.67B to 76.46B, a decrease of -37.16%. That is a compound annual growth rate of -4.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 76.46B | -13.99% |
| Dec 30, 2025 | 88.90B | 7.92% |
| Dec 30, 2024 | 82.38B | -12.98% |
| Dec 28, 2023 | 94.66B | 11.83% |
| Dec 29, 2022 | 84.65B | -13.49% |
| Dec 30, 2021 | 97.85B | -29.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 102.47B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 92.41B |
| Sam-A Pharm. | 91.49B |
| Polaris AI Pharma | 89.13B |
| Daehan Nupharm | 83.93B |
| Pharos iBio | 81.56B |
| GL Pharm Tech | 75.38B |
| Optipharm.CO.,LTD | 69.90B |